Agricultural Inputs
Compare Stocks
5 / 10Stock Comparison
CTVA vs FMC vs CF vs MOS vs NTR
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
Agricultural Inputs
Agricultural Inputs
Agricultural Inputs
CTVA vs FMC vs CF vs MOS vs NTR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Agricultural Inputs | Agricultural Inputs | Agricultural Inputs | Agricultural Inputs | Agricultural Inputs |
| Market Cap | $56.33B | $1.86B | $19.97B | $7.38B | $37.33B |
| Revenue (TTM) | $17.89B | $3.43B | $6.74B | $11.68B | $26.90B |
| Net Income (TTM) | $1.16B | $-2.50B | $1.38B | $1.22B | $2.27B |
| Gross Margin | 33.5% | 35.3% | 39.8% | 16.5% | 31.1% |
| Operating Margin | 13.8% | -59.5% | 35.1% | 9.9% | 13.4% |
| Forward P/E | 22.9x | 8.4x | 9.1x | 15.9x | 13.6x |
| Total Debt | $2.58B | $4.20B | $3.25B | $760M | $12.93B |
| Cash & Equiv. | $4.52B | $585M | $1.61B | $277M | $700M |
CTVA vs FMC vs CF vs MOS vs NTR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Corteva, Inc. (CTVA) | 100 | 307.3 | +207.3% |
| FMC Corporation (FMC) | 100 | 15.1 | -84.9% |
| CF Industries Holdi… (CF) | 100 | 436.0 | +336.0% |
| The Mosaic Company (MOS) | 100 | 192.4 | +92.4% |
| Nutrien Ltd. (NTR) | 100 | 227.2 | +127.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTVA vs FMC vs CF vs MOS vs NTR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTVA ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
- Beta 0.29, yield 0.8%, current ratio 1.43x
- Beta 0.29 vs FMC's 1.63, lower leverage
FMC is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 7 yrs, beta 1.63, yield 15.6%
- Lower P/E (8.4x vs 15.9x)
- 15.6% yield, 7-year raise streak, vs NTR's 2.9%
CF carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 362.9% 10Y total return vs CTVA's 203.3%
- 20.5% margin vs FMC's -72.9%
- +60.7% vs FMC's -54.9%
- 9.7% ROA vs FMC's -23.0%, ROIC 13.9% vs -21.2%
Among these 5 stocks, MOS doesn't own a clear edge in any measured category.
NTR is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 5.3%, EPS growth 248.5%, 3Y rev CAGR -10.3%
- PEG 0.33 vs CTVA's 1.92
- 5.3% revenue growth vs FMC's -18.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.3% revenue growth vs FMC's -18.3% | |
| Value | Lower P/E (8.4x vs 15.9x) | |
| Quality / Margins | 20.5% margin vs FMC's -72.9% | |
| Stability / Safety | Beta 0.29 vs FMC's 1.63, lower leverage | |
| Dividends | 15.6% yield, 7-year raise streak, vs NTR's 2.9% | |
| Momentum (1Y) | +60.7% vs FMC's -54.9% | |
| Efficiency (ROA) | 9.7% ROA vs FMC's -23.0%, ROIC 13.9% vs -21.2% |
CTVA vs FMC vs CF vs MOS vs NTR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CTVA vs FMC vs CF vs MOS vs NTR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CF leads in 3 of 6 categories
CTVA leads 0 • FMC leads 0 • MOS leads 0 • NTR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CF leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NTR is the larger business by revenue, generating $26.9B annually — 7.8x FMC's $3.4B. CF is the more profitable business, keeping 20.5% of every revenue dollar as net income compared to FMC's -72.9%. On growth, CF holds the edge at +21.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $17.9B | $3.4B | $6.7B | $11.7B | $26.9B |
| EBITDAEarnings before interest/tax | $3.4B | -$1.9B | $3.3B | $2.2B | $6.0B |
| Net IncomeAfter-tax profit | $1.2B | -$2.5B | $1.4B | $1.2B | $2.3B |
| Free Cash FlowCash after capex | $2.1B | -$91M | $1.7B | -$535M | $2.0B |
| Gross MarginGross profit ÷ Revenue | +33.5% | +35.3% | +39.8% | +16.5% | +31.1% |
| Operating MarginEBIT ÷ Revenue | +13.8% | -59.5% | +35.1% | +9.9% | +13.4% |
| Net MarginNet income ÷ Revenue | +6.5% | -72.9% | +20.5% | +10.5% | +8.4% |
| FCF MarginFCF ÷ Revenue | +11.5% | -2.7% | +25.4% | -4.6% | +7.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.0% | -4.1% | +21.1% | -7.5% | +6.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.6% | -17.8% | +41.3% | +3.8% | +4.2% |
Valuation Metrics
Evenly matched — FMC and MOS each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 6.0x trailing earnings, MOS trades at a 89% valuation discount to CTVA's 52.4x P/E. Adjusting for growth (PEG ratio), MOS offers better value at 0.35x vs CTVA's 4.39x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $56.3B | $1.9B | $20.0B | $7.4B | $37.3B |
| Enterprise ValueMkt cap + debt − cash | $54.4B | $5.5B | $21.6B | $7.9B | $49.6B |
| Trailing P/EPrice ÷ TTM EPS | 52.44x | -0.83x | 19.00x | 5.99x | 16.30x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.89x | 8.42x | 9.07x | 15.92x | 13.58x |
| PEG RatioP/E ÷ EPS growth rate | 4.39x | — | 0.76x | 0.35x | 0.40x |
| EV / EBITDAEnterprise value multiple | 14.23x | — | 8.09x | 3.64x | 7.78x |
| Price / SalesMarket cap ÷ Revenue | 3.24x | 0.54x | 3.36x | 0.63x | 1.36x |
| Price / BookPrice ÷ Book value/share | 2.32x | 0.89x | 3.05x | 0.56x | 1.48x |
| Price / FCFMarket cap ÷ FCF | 20.01x | — | 11.39x | — | 18.33x |
Profitability & Efficiency
CF leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CF delivers a 17.9% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-82 for FMC. MOS carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to FMC's 2.00x. On the Piotroski fundamental quality scale (0–9), NTR scores 8/9 vs FMC's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.6% | -82.3% | +17.9% | +10.0% | +9.0% |
| ROA (TTM)Return on assets | +2.7% | -23.0% | +9.7% | +5.0% | +4.3% |
| ROICReturn on invested capital | +8.5% | -21.2% | +13.9% | +6.1% | +8.0% |
| ROCEReturn on capital employed | +8.6% | -25.9% | +13.3% | +5.9% | +9.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 2 | 4 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.11x | 2.00x | 0.43x | 0.06x | 0.51x |
| Net DebtTotal debt minus cash | -$1.9B | $3.6B | $1.6B | $483M | $12.2B |
| Cash & Equiv.Liquid assets | $4.5B | $585M | $1.6B | $277M | $700M |
| Total DebtShort + long-term debt | $2.6B | $4.2B | $3.2B | $760M | $12.9B |
| Interest CoverageEBIT ÷ Interest expense | 5.82x | -0.24x | 13.86x | 8.81x | 5.24x |
Total Returns (Dividends Reinvested)
CF leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CF five years ago would be worth $27,264 today (with dividends reinvested), compared to $2,058 for FMC. Over the past 12 months, CF leads with a +60.7% total return vs FMC's -54.9%. The 3-year compound annual growth rate (CAGR) favors CF at 24.3% vs FMC's -43.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.1% | +4.3% | +60.4% | -6.2% | +23.2% |
| 1-Year ReturnPast 12 months | +35.6% | -54.9% | +60.7% | -21.1% | +41.3% |
| 3-Year ReturnCumulative with dividends | +47.5% | -81.6% | +92.0% | -34.0% | +28.7% |
| 5-Year ReturnCumulative with dividends | +82.6% | -79.4% | +172.6% | -22.6% | +48.3% |
| 10-Year ReturnCumulative with dividends | +203.3% | -25.3% | +362.9% | +11.1% | +70.2% |
| CAGR (3Y)Annualised 3-year return | +13.8% | -43.2% | +24.3% | -12.9% | +8.8% |
Risk & Volatility
Evenly matched — CTVA and CF each lead in 1 of 2 comparable metrics.
Risk & Volatility
CF is the less volatile stock with a -0.62 beta — it tends to amplify market swings less than FMC's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTVA currently trades 98.0% from its 52-week high vs FMC's 33.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | 1.63x | -0.62x | 0.52x | -0.07x |
| 52-Week HighHighest price in past year | $85.63 | $44.78 | $141.96 | $38.23 | $85.36 |
| 52-Week LowLowest price in past year | $60.54 | $12.17 | $75.42 | $22.74 | $53.03 |
| % of 52W HighCurrent price vs 52-week peak | +98.0% | +33.2% | +90.2% | +60.8% | +90.5% |
| RSI (14)Momentum oscillator 0–100 | 55.7 | 41.3 | 53.8 | 36.5 | 56.0 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 3.2M | 4.8M | 9.7M | 3.6M |
Analyst Outlook
Evenly matched — FMC and NTR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTVA as "Buy", FMC as "Hold", CF as "Buy", MOS as "Hold", NTR as "Buy". Consensus price targets imply 34.4% upside for MOS (target: $31) vs -15.0% for CF (target: $109). For income investors, FMC offers the higher dividend yield at 15.65% vs CTVA's 0.84%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $88.17 | $15.58 | $108.89 | $31.25 | $84.25 |
| # AnalystsCovering analysts | 37 | 42 | 41 | 49 | 33 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +15.6% | +1.6% | +4.1% | +2.9% |
| Dividend StreakConsecutive years of raises | 5 | 7 | 5 | 1 | 8 |
| Dividend / ShareAnnual DPS | $0.71 | $2.33 | $2.01 | $0.95 | $2.22 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.9% | +0.1% | +7.6% | 0.0% | +1.5% |
CF leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
CTVA vs FMC vs CF vs MOS vs NTR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTVA or FMC or CF or MOS or NTR a better buy right now?
For growth investors, Nutrien Ltd.
(NTR) is the stronger pick with 5. 3% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). The Mosaic Company (MOS) offers the better valuation at 6. 0x trailing P/E (15. 9x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTVA or FMC or CF or MOS or NTR?
On trailing P/E, The Mosaic Company (MOS) is the cheapest at 6.
0x versus Corteva, Inc. at 52. 4x. On forward P/E, FMC Corporation is actually cheaper at 8. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nutrien Ltd. wins at 0. 33x versus Corteva, Inc. 's 1. 92x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CTVA or FMC or CF or MOS or NTR?
Over the past 5 years, CF Industries Holdings, Inc.
(CF) delivered a total return of +172. 6%, compared to -79. 4% for FMC Corporation (FMC). Over 10 years, the gap is even starker: CF returned +362. 9% versus FMC's -25. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTVA or FMC or CF or MOS or NTR?
By beta (market sensitivity over 5 years), CF Industries Holdings, Inc.
(CF) is the lower-risk stock at -0. 62β versus FMC Corporation's 1. 63β — meaning FMC is approximately -361% more volatile than CF relative to the S&P 500. On balance sheet safety, The Mosaic Company (MOS) carries a lower debt/equity ratio of 6% versus 2% for FMC Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CTVA or FMC or CF or MOS or NTR?
By revenue growth (latest reported year), Nutrien Ltd.
(NTR) is pulling ahead at 5. 3% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: The Mosaic Company grew EPS 605. 5% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, CTVA leads at -0. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTVA or FMC or CF or MOS or NTR?
CF Industries Holdings, Inc.
(CF) is the more profitable company, earning 20. 5% net margin versus -64. 6% for FMC Corporation — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CF leads at 29. 4% versus -54. 4% for FMC. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTVA or FMC or CF or MOS or NTR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Nutrien Ltd. (NTR) is the more undervalued stock at a PEG of 0. 33x versus Corteva, Inc. 's 1. 92x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, FMC Corporation (FMC) trades at 8. 4x forward P/E versus 22. 9x for Corteva, Inc. — 14. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MOS: 34. 4% to $31. 25.
08Which pays a better dividend — CTVA or FMC or CF or MOS or NTR?
All stocks in this comparison pay dividends.
FMC Corporation (FMC) offers the highest yield at 15. 6%, versus 0. 8% for Corteva, Inc. (CTVA).
09Is CTVA or FMC or CF or MOS or NTR better for a retirement portfolio?
For long-horizon retirement investors, CF Industries Holdings, Inc.
(CF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 62), 1. 6% yield, +362. 9% 10Y return). FMC Corporation (FMC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CF: +362. 9%, FMC: -25. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTVA and FMC and CF and MOS and NTR?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CTVA is a mid-cap quality compounder stock; FMC is a small-cap income-oriented stock; CF is a mid-cap quality compounder stock; MOS is a small-cap deep-value stock; NTR is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.